Want to join the conversation?
$AMGN said it launched 6 new products last year, 2 in the cardiovascular arena and 4 in cancer. The company stated these products are still in the early stages of their launch cycle globally. $AMGN remains excited about the long-term prospects of Repatha and looks forward to important clinical data set to emerge later in 2016 and early 2017.
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!